中国防痨杂志 ›› 2020, Vol. 42 ›› Issue (7): 741-746.doi: 10.3969/j.issn.1000-6621.2020.07.018
姜丽*, 张晓强, 刘伶俐, 王晗, 刘峰, 李智越, 沈生荣(
)
收稿日期:2020-03-02
出版日期:2020-07-10
发布日期:2020-07-09
通信作者:
沈生荣
E-mail:shenshengrongzju@163.com
JIANG Li*, ZHANG Xiao-qiang, LIU Ling-li, WANG Han, LIU Feng, LI Zhi-yue, SHEN Sheng-rong(
)
Received:2020-03-02
Online:2020-07-10
Published:2020-07-09
Contact:
SHEN Sheng-rong
E-mail:shenshengrongzju@163.com
摘要:
营养不良是活动性结核病患者的常见结局之一,也是结核病患者早期死亡的危险因素。若不加以干预,结核病与营养不良间会形成一种恶性循环,导致结核病患者临床症状更为严重,治疗不良事件发生率更高,患者死亡风险更高。随着中国居民平均生活水平的提高及临床营养学的发展,对于结核病患者的营养管理,也逐渐开始重视起来。为更有针对性地设计营养补充方案,首先需要明确结核病患者各类营养素缺乏的具体情况。作者通过对国内外结核病营养研究现状进行分析,综合阐述了结核病患者宏量营养素、维生素和矿物质等各类营养素缺乏的临床特征,梳理了结核病患者的营养支持治疗思路,提出了各营养素的补充目标。
姜丽, 张晓强, 刘伶俐, 王晗, 刘峰, 李智越, 沈生荣. 结核病患者营养素缺乏临床特征研究进展[J]. 中国防痨杂志, 2020, 42(7): 741-746. doi: 10.3969/j.issn.1000-6621.2020.07.018
JIANG Li, ZHANG Xiao-qiang, LIU Ling-li, WANG Han, LIU Feng, LI Zhi-yue, SHEN Sheng-rong. Research progress of clinical characteristics of malnourished patients with tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(7): 741-746. doi: 10.3969/j.issn.1000-6621.2020.07.018
表1
蛋白质和能量补充对结核病治疗的影响
| 文献第一作者 (年份) | 国 别 | 补充营 养类型 | 受试者 | 样本量 (例) | 饮食结构 | 结果 |
|---|---|---|---|---|---|---|
| Paton(2004)[ | 新 加 坡 | 蛋白质、 能量 | 成年结核病患者,体质量指数(BMI)<20 | 36 | 补充治疗组:建议饮食标准,额外添加含2510~3766kJ的安素(含25~37.5g蛋白质),为期6周 对照组:建议饮食标准,为期6周 | 补充治疗组与对照组在第12周均出现体质量增加,分别为2.6kg和0.8kg;体质量和握力增加 |
| Martins(2009)[ | 东 帝 汶 | 蛋白质、 能量 | 成年结核病患者,80%的患者BMI<18.5 | 270 | 补充治疗组:建议饮食标准,额外添加含1799kJ的肉类(含18g蛋白质),2个月院内+6个月居家 对照组:建议饮食标准,2个月院内+6个月居家 | 补充治疗组与对照组在第8周体质量分别增加5.2kg和3.5kg |
| Sudarsanam(2011)[ | 印 度 | 蛋白质、 维生素、 微量元素、 能量 | 成年结核病患者,BMI≤19,其中22例患者并发HIV感染,CD4+ T淋巴细胞≤200 个/μl | 103 | 建议饮食标准,额外添加谷物和豆类混合物,能量约为3891kJ,蛋白质含量约31.5g,为期6个月 对照组:建议饮食标准,为期6个月 | 组间结果差异无统计学意义,但补充治疗组的结核病及结核病并发HIV感染者都有改善的趋势 |
| Jahnavi(2010)[ | 印 度 | 蛋白质、 维生素、 微量元素、 能量 | 成年结核病患者,BMI≤20 | 100 | 建议饮食标准,额外添加糖丸(一种补充能量的食物;含2510kJ能量和6g蛋白质),100g的坚果(用于补充维生素和矿物质),为期3个月 对照组:建议饮食标准,为期3个月 | 补充治疗组与对照组在第3个月均出现较为明显的体质量增加,分别为3.7kg 和1.1kg |
| [1] | World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. |
| [2] | Sinha P, Davis J, Saag L, et al. Undernutrition and Tuberculosis: Public Health Implications. J Infect Dis, 2019,219(9):1356-1363. doi: 10.1093/infdis/jiy675. |
| [3] | Chandrasekaran P, Saravanan N, Bethunaickan R, et al. Malnutrition: Modulator of Immune Responses in Tuberculosis. Front Immunol, 2017,8:1316. doi: 10.3389/fimmu.2017.01316. |
| [4] | Bakari M, Wamsele J, MacKenzie T, et al. Nutritional status of HIV-infected women with tuberculosis in Dar es Salaam, Tanzania. Public Health Action, 2013,3(3):224-229. doi: 10.5588/pha.13.0028. |
| [5] | Salamon H, Bruiners N, Lakehal K, et al. Cutting edge: Vitamin D regulates lipid metabolism in Mycobacterium tuberculosis infection. J Immunol, 2014,193(1):30-34. doi: 10.4049/jimmunol.1400736. |
| [6] | 周宁, 杜祥博, 杨莉, 等. 不同病程的结核病患者的血浆代谢组学研究. 波谱学杂志, 2016,33(2):224-233. doi: 10.11938/cjmr20160205. |
| [7] | Zhou A, Ni J, Xu Z, et al. Application of (1)h NMR spectroscopy-based metabolomics to sera of tuberculosis patients. J Proteome Res, 2013,12(10):4642-4649. doi: 10.1021/pr4007359. |
| [8] | 车纾慧, 付玉荣, 尹正君. 结核分枝杆菌感染致巨噬细胞脂代谢改变的研究进展. 中国人兽共患病学报, 2018,34(11):1044-1048. doi: 10.3969/j.issn.1002-2694.2018.00.193. |
| [9] | 张孝楠. 肺结核合并糖尿病患者的饮食及营养支持. 糖尿病新世界, 2016,19(14):106-107. doi: 10.16658/j.cnki.1672-4062.2016.14.106. |
| [10] | 邵立群, 赵飒. 营养治疗对2型糖尿病合并肺结核患者的影响. 中国现代药物应用, 2018,12(14):185-186. doi: 10.14164/j.cnki.cn11-5581/r.2018.14.108. |
| [11] | 陈荣娇, 梁志全, 杨荣, 等. 针对性饮食护理在老年肺结核伴糖尿病患者中的应用效果分析. 中国医药科学, 2018,8(12):167-169,192. doi: 10.3969/j.issn.2095-0616.2018.12.053. |
| [12] | Paton NI, Chua YK, Earnest A, et al. Randomized controlled trial of nutritional supplementation in patients with newly diagnosed tuberculosis and wasting. Am J Clin Nutr, 2004,80(2):460-465. doi: 10.1093/ajcn/80.2.460. |
| [13] | Martins N, Morris P, Kelly PM. Food incentives to improve completion of tuberculosis treatment: randomised controlled trial in Dili, Timor-Leste. BMJ, 2009,339:b4248. doi: 10.1136/bmj.b4248. |
| [14] | Sudarsanam TD, John J, Kang G, et al. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV-tuberculosis coinfection receiving directly observed short-course chemotherapy for tuberculosis. Trop Med Int Heal, 2011,16(6):699-706. doi: 10.1111/j.1365-3156.2011.02761.x. |
| [15] | Jahnavi G, Sudha CH. Randomised controlled trial of food supplements in patients with newly diagnosed tuberculosis and wasting. Singapore Med J, 2010,51(12):957-962. |
| [16] | World Health Organization. Guideline: Nutritional care and support for patients with tuberculosis. Geneva: World Health Organization, 2013. |
| [17] | 车纾慧, 付玉荣, 尹正君. 结核分枝杆菌感染致巨噬细胞脂代谢改变的研究进展. 中国人兽共患病学报, 2018,34(11):1044-1048. doi: 10.3969/j.issn.1002-2694.2018.00.193. |
| [18] | 刘国平. 结核病与血脂水平的相关性研究. 黑龙江医学, 2009,33(11):852-853. doi: 10.3969/j.issn.1004-5775.2009.11.023. |
| [19] | 崔学青, 付玉荣, 尹正君. 结核分枝杆菌感染对巨噬细胞内胆固醇代谢影响的机制的研究进展. 中国病原微生物学杂志, 2018,13(5):553-555. doi: 10.13350/j.cjpb.180523. |
| [20] | 李月, 刘凯, 方柯红, 等. 肺结核患者的膳食模式及其影响因素城乡差异的研究. 中国卫生统计, 2018,35(1):64-67. |
| [21] | 郑秀丽, 赖小惠, 梁月贞, 等. 高胆固醇饮食对肺结核患者相关指标改善情况分析. 延安大学学报(医学科学版), 2020,18(1):76-78. |
| [22] | Aibana O, Franke MF, Huang CC, et al. Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression. Clin Infect Dis, 2017,65(6):900-909. doi: 10.1093/cid/cix476. |
| [23] | Karyadi E, Schultink W, Nelwan RH, et al. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr, 2000,130(12):2953-2958. doi: 10.1093/jn/130.12.2953. |
| [24] | Mugusi FM, Rusizoka O, Habib N, et al. Vitamin A status of patients presenting with pulmonary tuberculosis and asymptomatic HIV-infected individuals, Dar es Salaam, Tanzania. Int J Tuberc Lung Dis, 2003,7(8):804-807. |
| [25] | Rwangabwoba JM, Fischman H, Semba RD. Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. Int J Tuberc Lung Dis, 1998,2(9):771-773. |
| [26] | Ramachandran G, Santha T, Garg R, et al. Vitamin A levels in sputum-positive pulmonary tuberculosis patients in comparison with household contacts and healthy ‘normals’. Int J Tuberc Lung Dis, 2004,8(9):1130-1133. |
| [27] | Kant S, Gupta H, Ahluwalia S. Significance of nutrition in pulmonary tuberculosis. Crit Rev Food Sci Nutr, 2015,55(7):955-963. doi: 10.1080/10408398.2012.679500. |
| [28] | Mishra A, Sarkar D. Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis. Front Microbiol, 2015,6:451. doi: 10.3389/fmicb.2015.00451. |
| [29] | Tornheim JA, Dooley KE. Tuberculosis Associated with HIV Infection. Microbiol Spectr, 2017,5(1). doi: 10.1128/microbiolspec.TNMI7-0028-2016. |
| [30] | Vilchèze C, Hartman T, Weinrick B, et al. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat Commun, 2013,4:1881. doi: 10.1038/ncomms2898. |
| [31] | 李新庆, 陈铁龙, 罗微. 高剂量维生素C辅助治疗继发性肺结核效果观察. 护理研究 2017,31(16):2019-2020. doi: 10.3969/j.issn.1009-6493.2017.16.029. |
| [32] | Khameneh B, Fazly Bazzaz BS, Amani A, et al. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog, 2016,93:83-87. doi: 10.1016/j.micpath.2015.11.006. |
| [33] | Zeng J, Wu G, Yang W, et al. A serum vitamin D level <25 nmol/l pose high tuberculosis risk: a meta-analysis. PLoS One, 2015,10(5):e0126014. doi: 10.1371/journal.pone.0126014. |
| [34] | Luong Kv, Nguyen LT. Impact of vitamin D in the treatment of tuberculosis. Am J Med Sci, 2011,341(6):493-498. doi: 10.1097/MAJ.0b013e3182070f47. |
| [35] | Nursyam EW, Amin Z, Rumende CM. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones, 2006,38(1):3-5. |
| [36] | Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomi-zed, placebo-controlled trial. Am J Respir Crit Care Med, 2009,179(9):843-850. doi: 10.1164/rccm.200804-567OC. |
| [37] | Nielsen NO, Skifte T, Andersson M, et al. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr, 2010,104(10):1487-1491. doi: 10.1017/S0007114510002333. |
| [38] | Ciftci TU, Ciftci B, Yis O, et al. Changes in serum selenium, copper, zinc levels and cu/zn ratio in patients with pulmonary tuberculosis during therapy. Biol Trace Elem Res, 2003,95(1):65-71. doi: 10.1385/BTER:95:1:65. |
| [39] | Koyanagi A, Kuffó D, Gresely L, et al. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis. Ann Trop Med Parasitol, 2004,98(4):391-399. doi: 10.1179/000349804225003424. |
| [40] | Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 1999,340(6):448-454. doi: 10.1056/NEJM199902113400607. |
| [41] | Graham NM, Sorensen D, Odaka N, et al. Relationship of serum copper and zinc levels to HIV-1 seropositivity and progression to AIDS. J Acquir Immune Defic Syndr, 1991,4(10):976-980. |
| [42] | Ramakrishnan K, Shenbagarathai R, Kavitha K, et al. Selenium levels in persons with HIV/tuberculosis in India, Madurai City. Clin Lab, 2012,58(1/2):165-168. |
| [43] | 李微, 张万江. 微量铁元素在结核病发病机制中作用的研究进展. 细胞与分子免疫学杂志, 2012,28(5):554-556. |
| [44] | Soeharto DA, Rifai DA, Marsudidjadja S, et al. Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report. Adv Prev Med, 2019: 5181847. doi: 10.1155/2019/5181847. |
| [45] | Feleke BE, Feleke TE, Mekonnen D, et al. Micronutrient levels of tuberculosis patients during the intensive phase, a prospective cohort study. Clin Nutr ESPEN, 2019,31:56-60. doi: 10.1016/j.clnesp.2019.03.001. |
| [46] | Panda S, Tiwari A, Luthra K, et al. Status of vitamin D and the associated host factors in pulmonary tuberculosis patients and their household contacts: A cross sectional study. J Steroid Biochem Mol Biol, 2019,193:105419. doi: 10.1016/j.jsbmb.2019.105419. |
| [47] | Khameneh B, Fazly Bazzaz BS, Amani A, et al. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb Pathog, 2016,93:83-87. doi: 10.1016/j.micpath.2015.11.006. |
| [48] | Elsafi SSMS, Nour BM, Abakar AD, et al. Vitamin D level and it is association with the severity of pulmonary tuberculosis in patients attended to Kosti Teaching Hospital, Sudan. AIMS Microbiol, 2020,6(1):65-74. doi: 10.3934/microbiol.2020004. |
| [49] | Kim EW, De Leon A, Jiang Z, et al. Vitamin A Metabolism by Dendritic Cells Triggers an Antimicrobial Response against Mycobacterium tuberculosis. mSphere, 2019,4(3):e00327-19. doi: 10.1128/mSphere.00327-19. |
| [50] | Nazarova EV, Montague CR, La T, et al. Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. Elife, 2017,6:e26969. doi: 10.7554/eLife.26969. |
| [51] | Wada T, Hanibuchi M, Saijo A. Acute hypercalcemia and hypervitaminosis D associated with pulmonary tuberculosis in an elderly patient: A case report and review of the literature. J Med Invest, 2019,66(3/4):351-354. doi: 10.2152/jmi.66.351. |
| [52] | Wilburn K, Fieweger RA, VanderVen BC. Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis. Pathogens and Disease, 2019,76:1-14. doi: 10.1155/2019/5181847. |
| [53] | 何广学. 我国结核病防治机构感染控制工作面临的挑战与对策. 结核病与肺部健康杂志, 2018,7(2):85-87. doi: 10.3969/j.issn.2095-3755.2018.02.001. |
| [54] | 中华医学会结核病学分会重症专业委员会. 结核病营养治疗专家共识. 中华结核和呼吸杂志, 2020,43(1):17-26. doi: 10.3760/cma.j.issn.1001-0939.2020.01.006. |
| [1] | 中国防痨协会结核病控制专业分会, 中国防痨协会青年分会, 《中国防痨杂志》编辑委员会. 中国结核病数字服药依从性技术应用指南[J]. 中国防痨杂志, 2025, 47(4): 385-397. |
| [2] | 李锦浩, 胡冬梅, 徐彩红. 结核病防治医务工作者开展预防性抗结核治疗工作意愿调查及影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 398-407. |
| [3] | 李玉红, 梅金周, 苏伟, 阮云洲, 刘玉舒, 赵雁林, 刘小秋. 2015—2021年全国65岁及以上老年利福平耐药肺结核患者治疗转归及影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 408-415. |
| [4] | 姜雪, 白云龙, 马建军, 安源, 杨帆, 赵庆龙. 2020—2023年吉林省利福平耐药肺结核患者诊治延迟现状及影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 416-424. |
| [5] | 吴璇, 张艳秋, 徐吉英, 孟丹, 孙定勇. 2019—2023年河南省肺结核合并糖尿病患者治疗转归影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 425-431. |
| [6] | 安源, 白云龙, 赵庆龙, 马建军, 姜雪, 潘艳, 高迎, 高智慧. 2018—2022年吉林省肺结核合并糖尿病患者治疗转归情况及影响因素分析[J]. 中国防痨杂志, 2025, 47(4): 432-438. |
| [7] | 冯畏, 郑海伦, 孟炜丽, 罗萍. 2018—2023年北京市西城区结核病防治机构登记管理肺结核患者到位前漏报情况分析[J]. 中国防痨杂志, 2025, 47(4): 439-443. |
| [8] | 胡一凡, 杜博平, 吴亚东, 朱传智, 张蓝月, 贾红彦, 孙琦, 潘丽萍, 张宗德, 李自慧. Mce4C蛋白参与结核分枝杆菌摄取利用胆固醇的实验研究[J]. 中国防痨杂志, 2025, 47(4): 444-453. |
| [9] | 盛杰, 洪凯峰, 米尔扎提·艾沙, 唐伟, 地里下提·阿不力孜. 白细胞介素22和p38 MAPK信号通路抑制骨关节结核骨质破坏的作用机制研究[J]. 中国防痨杂志, 2025, 47(4): 454-459. |
| [10] | 王颖超, 刘唯夷, 姬秀秀, 尚雪恬, 贾红彦, 张蓝月, 孙琦, 杜博平, 朱传智, 潘丽萍, 张宗德. 结核病患者外周血单个核细胞内环状RNA表达谱分析及诊断标识的鉴定[J]. 中国防痨杂志, 2025, 47(4): 460-470. |
| [11] | 朱明智, 邵燕琴, 范大鹏, 刘立宾, 梅宾, 戴玲珊, 蔡龙. 尿液脂阿拉伯甘露聚糖抗原检测对肺外结核的诊断价值[J]. 中国防痨杂志, 2025, 47(4): 471-476. |
| [12] | 郝明晓, 米洁, 许宗仪. 延续性护理路径在结核性脑膜炎患者中的应用效果分析[J]. 中国防痨杂志, 2025, 47(4): 477-481. |
| [13] | 尚希钰, 张慧芳, 曹玉清, 熊一白, 纪鑫毓, 田雅欣, 李佳佳, 王倪, 马艳. 基于文献计量学的结核病中医药基础研究全球研究现状及热点分析[J]. 中国防痨杂志, 2025, 47(4): 482-497. |
| [14] | 秦丽莉, 杨澄清, 麦洪珍, 徐齐峰, 薛新颖, 路希维. 结核后肺曲霉病的临床诊疗研究进展[J]. 中国防痨杂志, 2025, 47(4): 498-504. |
| [15] | 罗莉, 罗林紫, 尹曲华, 周磊, 卢志斌, 丁衍, 肖阳宝. 淋巴结瘘型气管支气管结核的支气管镜下诊疗进展[J]. 中国防痨杂志, 2025, 47(4): 505-512. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
京公网安备11010202007215号
ip访问总数: ip当日访问总数: 当前在线人数:
本作品遵循Creative Commons Attribution 3.0 License授权许可